Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Monotherapy with a novel intervenolin derivative, AS-1934, is an effective treatment for Helicobacter pylori infection.

Ohishi T, Masuda T, Abe H, Hayashi C, Adachi H, Ohba SI, Igarashi M, Watanabe T, Mimuro H, Amalia E, Inaoka DK, Mochizuki K, Kita K, Shibasaki M, Kawada M.

Helicobacter. 2018 Apr;23(2):e12470. doi: 10.1111/hel.12470. Epub 2018 Feb 28.

PMID:
29488678
2.

Biological activity of intervenolin analogs with a phenyl substituent.

Abe H, Kawada M, Igarashi M, Ohba SI, Hayashi C, Sakashita C, Watanabe T, Shibasaki M.

J Antibiot (Tokyo). 2017 Oct 11. doi: 10.1038/ja.2017.123. [Epub ahead of print]

PMID:
29018268
3.

[Self-help intervention delivered via devices].

Okajima I.

Nihon Rinsho. 2015 Jun;73(6):1006-9. Review. Japanese.

PMID:
26065133
4.

Intervenolin, a new antitumor compound with anti-Helicobacter pylori activity, from Nocardia sp. ML96-86F2.

Kawada M, Inoue H, Ohba S, Hatano M, Amemiya M, Hayashi C, Usami I, Abe H, Watanabe T, Kinoshita N, Igarashi M, Masuda T, Ikeda D, Nomoto A.

J Antibiot (Tokyo). 2013 Sep;66(9):543-8. doi: 10.1038/ja.2013.42. Epub 2013 May 1.

PMID:
23632919
5.

Synthesis of intervenolin, an antitumor natural quinolone with unusual substituents.

Abe H, Kawada M, Inoue H, Ohba S, Nomoto A, Watanabe T, Shibasaki M.

Org Lett. 2013 May 3;15(9):2124-7. doi: 10.1021/ol400587a. Epub 2013 Apr 17.

PMID:
23594173

Supplemental Content

Loading ...
Support Center